Author: Deng, Xufang; Baker, Susan C
Title: An “Old†Protein with A New Story: Coronavirus Endoribonuclease Is Important for Evading Host Antiviral Defenses Cord-id: vox5xsgd Document date: 2018_4_1
ID: vox5xsgd
Snippet: Here we review the evolving story of the coronavirus endoribonuclease (EndoU). Coronavirus EndoU is encoded within the sequence of nonstructural protein (nsp) 15, which was initially identified as a component of the viral replication complex. Biochemical and structural studies revealed the enzymatic nature of nsp15/EndoU, which was postulated to be essential for the unique replication cycle of viruses in the order Nidovirales. However, the role of nsp15 in coronavirus replication was enigmatic a
Document: Here we review the evolving story of the coronavirus endoribonuclease (EndoU). Coronavirus EndoU is encoded within the sequence of nonstructural protein (nsp) 15, which was initially identified as a component of the viral replication complex. Biochemical and structural studies revealed the enzymatic nature of nsp15/EndoU, which was postulated to be essential for the unique replication cycle of viruses in the order Nidovirales. However, the role of nsp15 in coronavirus replication was enigmatic as EndoU-deficient coronaviruses were viable and replicated to near wild-type virus levels in fibroblast cells. A breakthrough in our understanding of the role of EndoU was revealed in recent studies, which showed that EndoU mediates the evasion of viral double-stranded RNA recognition by host sensors in macrophages. This new discovery of nsp15/EndoU function leads to new opportunities for investigating how a viral EndoU contributes to pathogenesis and exploiting this enzyme for therapeutics and vaccine design against pathogenic coronaviruses.
Search related documents:
Co phrase search for related documents- activate pkr and long dsrna: 1, 2
- active site and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active site and additional study: 1, 2
- active site and live virus: 1, 2, 3, 4
- active site and long dsrna: 1
- active site and long dsrnas: 1
- activity cofactor and acute sars respiratory syndrome: 1, 2, 3
- activity inhibition and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activity inhibition and additional study: 1, 2
- activity inhibition and live virus: 1, 2
- activity inhibition and log reduction: 1, 2, 3
- activity inhibition and log viral titer: 1
- acute sars respiratory syndrome and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute sars respiratory syndrome and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars respiratory syndrome and liver specific: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute sars respiratory syndrome and log reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars respiratory syndrome and log viral titer: 1, 2
- additional study and live virus: 1
- live virus and log reduction: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date